Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

They also obtained smoking cessation treatment, exercise and weight counseling, and pneumonia and flu vaccines, if appropriate. Of the people seen by a lung specialist or asthma/COPD educator ...

In 2001,123 013 deaths, 726 000 hospitalizations,and 1.5 million emergency department visitswere caused by COPD. 12 An additional 8million cases of hospital outpatient treatmentor treatment by ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

In a recent study ... respiratory symptoms might be living with undiagnosed COPD and missing out on the opportunity to receive treatment. In a study, published in JAMA titled "Polygenic Risk ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

RAs, and DPP-4is may offer benefits for patients with COPD, but clinical evidence comparing their effectiveness in reducing COPD exacerbations in patients with T2D remains limited. This study aimed to ...